Repositioning FDA-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer Epigenome

Title
Repositioning FDA-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer Epigenome
Authors
Keywords
-
Journal
MOLECULAR CANCER THERAPEUTICS
Volume 16, Issue 2, Pages 397-407
Publisher
American Association for Cancer Research (AACR)
Online
2016-12-16
DOI
10.1158/1535-7163.mct-16-0588

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started